Drug Survival of Dupilumab, Tralokinumab and Upadacitinib in Patients with Atopic Dermatitis
AuthID
P-018-NT3
P-018-NT3
© 2025 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service